These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 10733008)

  • 21. Cerebral dysfunction in chronic alcoholism: role of alcoholic liver disease.
    Butterworth RF
    Alcohol Alcohol Suppl; 1994; 2():259-65. PubMed ID: 8974345
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Traumatic brain injury leads to increased expression of peripheral-type benzodiazepine receptors, neuronal death, and activation of astrocytes and microglia in rat thalamus.
    Raghavendra Rao VL; Dogan A; Bowen KK; Dempsey RJ
    Exp Neurol; 2000 Jan; 161(1):102-14. PubMed ID: 10683277
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Brain GABA and benzodiazepine receptors in hepatic encephalopathy.
    Butterworth RF
    Rev Invest Clin; 1990 Jul; 42 Suppl():137-40. PubMed ID: 19256153
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Densities of binding sites for the "peripheral-type" benzodiazepine receptor ligand 3H-PK11195 are increased in brain 24 hours following portacaval anastomosis.
    Leong DK; Therrien G; Swain MS; Butterworth RF
    Metab Brain Dis; 1994 Sep; 9(3):267-73. PubMed ID: 7838068
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pathophysiology of hepatic encephalopathy: a new look at ammonia.
    Butterworth RF
    Metab Brain Dis; 2002 Dec; 17(4):221-7. PubMed ID: 12602499
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Ammonia and GABA-ergic neurotransmission in pathogenesis of hepatic encephalopathy].
    Helewski K; Kowalczyk-Ziomek G; Konecki J
    Wiad Lek; 2003; 56(11-12):560-3. PubMed ID: 15058165
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pathogenesis of hepatic encephalopathy: update on molecular mechanisms.
    Butterworth RF
    Indian J Gastroenterol; 2003 Dec; 22 Suppl 2():S11-6. PubMed ID: 15025246
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Tissue-specific alterations of binding sites for peripheral-type benzodiazepine receptor ligand [3H]PK11195 in rats following portacaval anastomosis.
    Rao VL; Audet R; Therrien G; Butterworth RF
    Dig Dis Sci; 1994 May; 39(5):1055-63. PubMed ID: 8174418
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Astrocytes and manganese neurotoxicity.
    Hazell AS
    Neurochem Int; 2002 Oct; 41(4):271-7. PubMed ID: 12106778
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The pathogenesis and treatment of hepatic encephalopathy: evidence for the involvement of benzodiazepine receptor ligands.
    Basile AS; Jones EA; Skolnick P
    Pharmacol Rev; 1991 Mar; 43(1):27-71. PubMed ID: 1674609
    [No Abstract]   [Full Text] [Related]  

  • 31. The neurosteroid system: an emerging therapeutic target for hepatic encephalopathy.
    Ahboucha S; Butterworth RF
    Metab Brain Dis; 2007 Dec; 22(3-4):291-308. PubMed ID: 17823858
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Complications of cirrhosis III. Hepatic encephalopathy.
    Butterworth RF
    J Hepatol; 2000; 32(1 Suppl):171-80. PubMed ID: 10728803
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Increased "peripheral-type" benzodiazepine receptor sites and mRNA in thalamus of thiamine-deficient rats.
    Desjardins P; Todd KG; Hazell AS; Butterworth RF
    Neurochem Int; 1999 Nov; 35(5):363-9. PubMed ID: 10517697
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The peripheral benzodiazepine receptor and neurosteroids in hepatic encephalopathy.
    Norenberg MD; Itzhak Y; Bender AS
    Adv Exp Med Biol; 1997; 420():95-111. PubMed ID: 9286429
    [No Abstract]   [Full Text] [Related]  

  • 35. Increased densities of binding sites for the peripheral-type benzodiazepine receptor ligand [3H]PK 11195 in congenital ornithine transcarbamylase-deficient sparse fur mouse.
    Rao VL; Qureshi IA; Butterworth RF
    Pediatr Res; 1993 Dec; 34(6):777-80. PubMed ID: 8108192
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The GABA hypothesis of the pathogenesis of hepatic encephalopathy: current status.
    Jones EA; Schafer DF; Ferenci P; Pappas SC
    Yale J Biol Med; 1984; 57(3):301-16. PubMed ID: 6093394
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Experimental studies on peripheral-type benzodiazepine receptors in brain in rats with hepatic encephalopathy].
    Zhang ZM; Qiu FZ; Chen XP
    Zhonghua Wai Ke Za Zhi; 1994 Jan; 32(1):37-40. PubMed ID: 8045200
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Affinities and densities of high-affinity [3H]muscimol (GABA-A) binding sites and of central benzodiazepine receptors are unchanged in autopsied brain tissue from cirrhotic patients with hepatic encephalopathy.
    Butterworth RF; Lavoie J; Giguère JF; Pomier-Layrargues G
    Hepatology; 1988; 8(5):1084-8. PubMed ID: 2843451
    [TBL] [Abstract][Full Text] [Related]  

  • 39. NIH conference. The gamma-aminobutyric acid A (GABAA) receptor complex and hepatic encephalopathy. Some recent advances.
    Jones EA; Skolnick P; Gammal SH; Basile AS; Mullen KD
    Ann Intern Med; 1989 Apr; 110(7):532-46. PubMed ID: 2538099
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Loss of noradrenaline transporter sites in frontal cortex of rats with acute (ischemic) liver failure.
    Michalak A; Rose C; Butterworth RF
    Neurochem Int; 2001 Jan; 38(1):25-30. PubMed ID: 10913685
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.